446 related articles for article (PubMed ID: 28584141)
1. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
2. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
3. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
Ortines RV; Wang Y; Liu H; Dikeman DA; Pinsker BL; Miller RJ; Kim SE; Ackerman NE; Rizkallah JF; Marcello LT; Cohen TS; Tkaczyk C; Sellman BR; Miller LS
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138566
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies neutralizing alpha-hemolysin, bicomponent leukocidins, and clumping factor A protected against
Nguyen NTQ; Doan TNM; Sato K; Tkaczyk C; Sellman BR; Diep BA
Front Immunol; 2023; 14():1260627. PubMed ID: 37781371
[TBL] [Abstract][Full Text] [Related]
10. Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity
Tkaczyk C; Semenova E; Shi YY; Rosenthal K; Oganesyan V; Warrener P; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150481
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.
Tabor DE; Yu L; Mok H; Tkaczyk C; Sellman BR; Wu Y; Oganesyan V; Slidel T; Jafri H; McCarthy M; Bradford P; Esser MT
Antimicrob Agents Chemother; 2016 Sep; 60(9):5312-21. PubMed ID: 27324766
[TBL] [Abstract][Full Text] [Related]
12. Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections.
Le VT; Tkaczyk C; Chau S; Rao RL; Dip EC; Pereira-Franchi EP; Cheng L; Lee S; Koelkebeck H; Hilliard JJ; Yu XQ; Datta V; Nguyen V; Weiss W; Prokai L; O'Day T; Stover CK; Sellman BR; Diep BA
Antimicrob Agents Chemother; 2016 Oct; 60(10):5640-8. PubMed ID: 27401576
[TBL] [Abstract][Full Text] [Related]
13. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin.
Diep BA; Le VT; Visram ZC; Rouha H; Stulik L; Dip EC; Nagy G; Nagy E
Antimicrob Agents Chemother; 2016 Oct; 60(10):6333-40. PubMed ID: 27527081
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
15. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
[TBL] [Abstract][Full Text] [Related]
16. A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia.
van den Berg S; Bonarius HP; van Kessel KP; Elsinga GS; Kooi N; Westra H; Bosma T; van der Kooi-Pol MM; Koedijk DG; Groen H; van Dijl JM; Buist G; Bakker-Woudenberg IA
Int J Med Microbiol; 2015 Jan; 305(1):55-64. PubMed ID: 25466204
[TBL] [Abstract][Full Text] [Related]
17. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
[No Abstract] [Full Text] [Related]
18. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
19. Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody.
Rouha H; Badarau A; Visram ZC; Battles MB; Prinz B; Magyarics Z; Nagy G; Mirkina I; Stulik L; Zerbs M; Jägerhofer M; Maierhofer B; Teubenbacher A; Dolezilkova I; Gross K; Banerjee S; Zauner G; Malafa S; Zmajkovic J; Maier S; Mabry R; Krauland E; Wittrup KD; Gerngross TU; Nagy E
MAbs; 2015; 7(1):243-54. PubMed ID: 25523282
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.
Hilliard JJ; Datta V; Tkaczyk C; Hamilton M; Sadowska A; Jones-Nelson O; O'Day T; Weiss WJ; Szarka S; Nguyen V; Prokai L; Suzich J; Stover CK; Sellman BR
Antimicrob Agents Chemother; 2015 Jan; 59(1):299-309. PubMed ID: 25348518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
